PSYCHIATRIC COMORBIDITIES IN PATIENTS WITH SUBSTANCE USE DISORDERS COMING FOR DE-ADDICTION TREATMENT IN A TERTIARY CARE HOSPITAL OF WESTERN INDIA.

Basu D, Gupta N. Management of "dual diagnosis" patients: consensus, controversies and considerations. Indian J Psychiatry 2000;42(1):34-47.      

Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264(19):2511-8.             

Morojele NK, Saban A, Seedat S. Clinical presentations and diagnostic issues in dual diagnosis disorders. Curr Opin Psychiatry 2012;25(3):181-6.      

Morisano D, Babor TF, Robaina KA. Co-occurrence of substance use disorders with other psychiatric disorders: implications for treatment services. Nordic Studies on Alcohol and Drugs, First Published April 12, 2017.

The ICD-10: classification of mental health and Behavioral Disorders. Diagnostic Criteria for research, Geneva, World Health Organisation, 1993.          

Goldberg DP. The General Health Questionnaire (GHQ): Companion to Psychiatric studies. Oxford University Press 1972: p. 172-3.  

Kapur RL, Kapur M, Carstairs GM. Indian Psychiatric Interview Schedule (IPIS). Social Psychiatry 1974;9:61-69.            

Subodh BN, Hazari N, Elwadhi D, et al. Prevalence of dual diagnosis among clinic attending patients in a de-addiction centre of a tertiary care hospital. Asian Journal of Psychiatry 2017;25:169-74.            

Ahmad B, Mufti KA, Farooq S. Psychiatric comorbidity in substance abuse (opioids). Journal of Pakistan Medical Association 2001;51(5):183-6.   

Midha PK, Kanwal K, Batra L. A study of comorbidity in patients abusing substance. Journal of Mental Health and Human Behavior 2001;6:137-45.

Rui C, Rui R, Elisabete R, et al. Depression and the severity of substance abuse. Psychopathology (International Journal of Descriptive and Experimental Psychopathology, Phenomenology and Psychiatric Diagnosis) 2000;33(3).               

Goeb, JL, Coste J, Bigot T, et al. Prospective study of favorable factors in follow up study of drug addicted patients—apropos of 257 patients of the Cassini center in Paris. Encephale 2000;26(6):11-20.         

Brooner RK, King VL, Kidorf M, et al. Psychiatric and substance use comorbidity among treatment seeking opioid abusers. Archives of General Psychiatry 1997;54(1):71-80.        

Charney DA, Palacios-Boix J, Negrete JC, et al. Association between concurrent depression and anxiety and six-month outcome of addiction treatment. Psychiatry Survey 2005;56(8):927-33.               

Kessler RC, Nelson CB, McGonagle KA, et al. The epidemiology of co-occuring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996;66(1):17-31.              

Dake S, Hall W, Swift W. Prevalence, symptoms and correlates of antisocial personality disorders among methadone maintenance clients. Drug Alcohol Depend 1994;34(3):253-7.                                 

Von Limbeek J, Wouters L, Kaplan CD, et al. Prevalence of Psychopathology in drug-addicted Dutch. J Subst Abuse Treat 1992;9(1):43-52.     

Błachut M, Badura-Brzoza K, Jarzab M, et al. Dual diagnosis in psychoactive substance abusing or dependent persons. Psychiatr Pol 2013;47(2):335-52.                   

Gania AM, Margoob MA, Shah HU, et al. Psychiatric comorbidity in patients with substance use disorder: a hospital-based study. Indian J Soc Psychiatry 2017;33(1):63-6.               

Balhara YPS, Sarkar S, Bera SC, et al. Who seeks treatment for dual disorders? Observations from a dual disorder clinic at the National Drug Dependence Treatment Centre in India over a 12 year period. Int J High Risk Behav Addict 2017;6(1):e32501.          

Basu D, Sarkar S, Mattoo SK. Psychiatric comorbidity in patients with substance use disorders attending an addiction treatment center in india over 11 years: case for a specialized “dual diagnosis clinic”. Journal of Dual Diagnosis 2012;9(1):23-9.

Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry 1999;56(7):617-26.       

Maloney E, Degenhardt L, Darke S, et al. Suicidal behaviour and associated risk factors among opioid-dependent individuals: a case-control study. Addiction 2007;102(12):1933-41.                   

Ilgen MA, Burnette ML, Conner KR, et al. The association between violence and lifetime suicidal thoughts and behaviors in individuals treated for substance use disorders. Addict Behav 2010;35(2):111-5.          

Roy A. Characteristics of cocaine dependent patients who attempt suicide. Arch Suicide Res 2009;13(1):46-51.                  

Ilgen MA, Harris AH, Moos RH, et al. Predictors of a suicide attempt one year after entry into substance use disorder treatment. Alcohol Clin Exp Res 2007;31(4):635-42.              

Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997;170(3):205-28.        

Conner KR, Pinquart M, Gamble SA. Meta-analysis of depression and substance use among individuals with alcohol use disorders. J Subst Abuse Treat 2009;37(2):127-37.